Clinical Trials on Locally Advanced Head and Neck Squamous Cell Carcinoma in Germany
Total 317 results
-
University of Erlangen-Nürnberg Medical SchoolCompletedLocally Advanced Head and Neck Squamous Cell CarcinomaGermany
-
European Organisation for Research and Treatment...Merck KGaA, Darmstadt, GermanyRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaFrance, Belgium, Netherlands, Norway, United Kingdom, Ireland, Italy, Slovenia, Germany, Spain
-
AstraZenecaRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaUnited States, Spain, Italy, Canada, Korea, Republic of, United Kingdom, Germany, Vietnam, Japan, France, India, Taiwan, Thailand, Malaysia, Turkey, Brazil, Belgium, Poland, Austria, Hungary
-
NanobiotixRecruitingAged | Locally Advanced Head and Neck Squamous Cell CarcinomaFrance, Spain, Israel, United States, Taiwan, Finland, Japan, Belgium, Korea, Republic of, Hungary, China, Georgia, Portugal, Austria, Bulgaria, Canada, Czechia, Germany, Greece, Romania, Serbia
-
Replimune Inc.Bristol-Myers SquibbWithdrawnSquamous Cell Carcinoma of Head and Neck | Recurrent Head and Neck Squamous Cell Carcinoma | Locally Advanced Head and Neck Squamous Cell CarcinomaUnited States, Spain, United Kingdom, Czechia, France, Germany, Greece, Poland
-
Hoffmann-La RocheTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Korea, Republic of, Canada, Australia, Russian Federation, United Kingdom, Belgium, Brazil, China, France, Italy, Portugal, Spain, Japan, India, Thailand, Ukraine, Taiwan, Poland, Turkey, Hungary, South Africa, Germany
-
Heidelberg UniversityUniversity Hospital HeidelbergTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal CancerGermany
-
European Organisation for Research and Treatment...Danish Head and Neck Cancer GroupActive, not recruitingLocally Advanced Head and Neck HPV Negative Squamous Cell CancersBelgium, France, Poland, Australia, Germany, Netherlands, Switzerland
-
Bristol-Myers SquibbActive, not recruiting
-
Charite University, Berlin, GermanyHelmholtz-Zentrum Dresden-Rossendorf; Max-Delbrück-Centrum BerlinRecruiting
-
AstraZenecaMedImmune LLCActive, not recruitingAdvanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and NeckSpain, United States, Belgium, Germany, United Kingdom, Italy
-
Technical University of MunichRecruitingHead and Neck Squamous Cell CarcinomaGermany
-
University of Erlangen-Nürnberg Medical SchoolActive, not recruiting
-
AIO-Studien-gGmbHBristol-Myers SquibbCompletedCarcinoma, Squamous Cell of Head and Neck | Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckGermany
-
Ulrich KeilholzCharite University, Berlin, Germany; AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckGermany
-
Technische Universität DresdenGerman Cancer Research Center; National Center for Tumor Diseases, Heidelberg; Radiation Oncology Working Group of the German Cancer Society and other collaboratorsRecruitingHead-and-neck Squamous Cell CarcinomaGermany
-
Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, Squamous Cell of Head and NeckGermany
-
AbbVieIdera Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors CancerUnited States, France, Germany, Israel, Netherlands, Spain
-
University Hospital TuebingenUnknownSquamous Cell Carcinoma of the Head and NeckGermany
-
University of LeipzigRecruiting
-
University Hospital, EssenCompletedWindow of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN (PIONEER)Squamous Cell Carcinoma of Head and NeckGermany
-
Martin-Luther-Universität Halle-WittenbergUltimovacs ASA; Apotheke der Universitätsmedizin der Johannes Gutenberg-Universität... and other collaboratorsRecruitingHead and Neck Squamous Cell CarcinomaGermany
-
Ascendis Pharma Oncology Division A/SRecruitingHead and Neck NeoplasmsUnited States, Spain, Georgia, Hungary, Germany, Italy, Taiwan
-
AstraZenecaCompletedNeoplasms, Squamous CellUnited States, Czech Republic, Poland, Germany, Belgium, Taiwan, India, Serbia
-
Hannover Medical SchoolCompletedHead and Neck Squamous Cell CarcinomaGermany
-
Symphogen A/SCompletedCarcinoma, Squamous Cell of Head and NeckBelgium, France, Germany
-
University of Erlangen-Nürnberg Medical SchoolRecruitingSquamous Cell Carcinoma of Head and NeckGermany
-
Universität des SaarlandesRecruitingHead and Neck Squamous Cell CarcinomaGermany
-
PCI Biotech ASTerminatedRecurrent Head and Neck Cancer | Carcinoma, Squamous Cell of Head and NeckGermany, United Kingdom, France, Lithuania, Netherlands, Poland
-
Genentech, Inc.CompletedHead and Neck CancerUnited States, Germany, Spain, France, Australia, Hungary, Belgium, Bulgaria, United Kingdom, Italy, Romania
-
GlaxoSmithKlineRecruitingNeoplasms, Head and NeckUnited States, Italy, Japan, Norway, Spain, Taiwan, Australia, United Kingdom, Belgium, Brazil, Germany, Greece, Romania, Sweden, Turkey, Canada, Korea, Republic of, China, France, Argentina, India, Poland, Israel, Portugal, Mexico, Czechia, Hunga...
-
Gilead SciencesActive, not recruitingHead and Neck Squamous Cell CarcinomaUnited States, France, Spain, Australia, Italy, Belgium, Hong Kong, Portugal, Poland, United Kingdom, Germany
-
SanofiGroupe Oncologie Radiotherapie Tete et CouCompletedHead and Neck Squamous Cell CarcinomaUnited States, France, Canada, Poland, Germany, Spain, Switzerland, Singapore, Taiwan, Argentina, Hungary, Italy, Chile, Hong Kong, South Africa, Australia, New Zealand
-
GlaxoSmithKlineMerck Sharp & Dohme LLCTerminatedNeoplasms, Head and NeckUnited States, Argentina, Italy, Spain, Belgium, Denmark, Poland, Canada, Germany, Korea, Republic of, Ireland, Japan, United Kingdom, Romania, Hungary, Australia, France, Brazil, Sweden, Russian Federation
-
Glycotope GmbHCompletedCetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer (RESGEX)Carcinoma, Squamous Cell of Head and NeckBelgium, France, Germany, Italy, Poland, Romania, Spain
-
Merck KGaA, Darmstadt, GermanyCompletedHead and Neck CancerFrance, Russian Federation, Spain, United Kingdom, Germany, Hungary, Poland, Ukraine, Austria, Netherlands, Slovakia, Sweden, Switzerland, Belgium, Italy, Portugal, Czech Republic
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Italy, Korea, Republic of, Spain, Greece, Germany, Japan
-
Technische Universität DresdenNot yet recruitingHead and Neck Squamous Cell CarcinomaGermany
-
GlaxoSmithKlineiTeos TherapeuticsRecruitingNeoplasms, Head and NeckUnited States, Italy, Spain, Taiwan, Germany, Greece, Korea, Republic of, Romania, Sweden, Turkey, Canada, Argentina, Finland, Brazil, Japan, Poland, Portugal, France, Denmark, Hungary, Norway
-
AstraZenecaPRA Health SciencesCompletedRecurrent/Metastatic Squamous Cell Carcinoma of Head & NeckUnited States, Canada, France, Spain, Belgium, Czechia, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Australia, Germany, Georgia, Israel
-
BioNTech SERecruitingRecurrent Head and Neck Cancer | Unresectable Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck CancerGermany, United States, France, United Kingdom, Korea, Republic of, Spain, Poland, Belgium, Brazil, Taiwan, Italy, Canada, Czechia, Australia, Turkey, Mexico, Chile, Argentina, Austria, Hungary, Portugal, Sweden
-
Charite University, Berlin, GermanyCompletedSquamous Cell Carcinoma of the Neck | Squamous Cell Carcinoma of the HeadGermany
-
Novartis PharmaceuticalsTerminatedHead and Neck Squamous Cell CarcinomaGermany, United Kingdom, United States, Spain, Italy, Canada, Poland, Russian Federation, Switzerland, Thailand, Korea, Republic of, Hungary, Ireland, Australia, Taiwan, France, India, Japan
-
Groupe Oncologie Radiotherapie Tete et CouAIO-Studien-gGmbH; Grupo Español de Tratamiento de Tumores de Cabeza y CuelloCompletedHead and Neck Squamous Cell CarcinomaFrance, Germany, Spain
-
Incyte Biosciences International SàrlRecruitingHead and Neck CancerUnited States, Taiwan, Italy, Korea, Republic of, Spain, France, Portugal, Germany, Poland, Canada, Georgia, Greece, Netherlands, Belgium
-
GlaxoSmithKlineMerck Sharp & Dohme LLCTerminatedNeoplasms, Head and NeckUnited States, Argentina, Australia, Spain, Taiwan, Germany, Israel, Poland, Canada, Japan, Portugal, Ireland, Netherlands, China, Brazil, France, Korea, Republic of, Italy, Romania, Russian Federation, United Kingdom, Norway, Switz... and more
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHead and Neck CancerItaly, United States, Israel, Japan, Australia, Austria, Brazil, France, Germany, Greece, Ireland, Korea, Republic of, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom
-
AIO-Studien-gGmbHMerck Sharp & Dohme LLCNot yet recruitingSquamous Cell Carcinoma of the Larynx | Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Oropharynx | Squamous Cell Carcinoma of the HypopharynxGermany
-
PfizerTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, China, Taiwan, France, Australia, Hungary, Korea, Republic of, Germany, Japan, Switzerland, Ireland, Israel, United Kingdom, Italy, Poland, Belgium, Canada, Greece, Portugal, Austria, Russian Federation
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...Active, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more